NCT01772810View on ClinicalTrials.gov

Safety Study of Human Spinal Cord-derived Neural Stem Cell Transplantation for the Treatment of Chronic SCI

PHASE1UnknownINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

July 31, 2018

Study Completion Date

December 31, 2022

Conditions
Spinal Cord Injury (SCI)
Interventions
DRUG

Human spinal cord stem cells.

Human spinal cord stem cell implantation in paralysis patients due to a spinal cord injury.

Trial Locations (1)

92103-8893

RECRUITING

UCSD Medical Center, Division of Neurosurgery, San Diego

Sponsors

Lead Sponsor

Neuralstem Inc.
All Listed Sponsors
lead

Neuralstem Inc.

INDUSTRY